Azerbaijan vs Peru: Access to anti-retroviral drugs, male
Azerbaijan
80.0%
in 2024
Peru
79.0%
in 2024
Azerbaijan rank
47th
Peru rank
49th
Access to anti-retroviral drugs, male over time
- Azerbaijan
- Peru
How they compare
Azerbaijan currently reports 80.0% against 79.0% in Peru, a difference of 1.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Peru ahead.
Azerbaijan ranks 47th and Peru ranks 49th of 141 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 6.3% | 5.7% | Peru |
| 2010s | 23.7% | 43.1% | 19.4% | Peru |
| 2020s | 65.2% | 74.4% | 9.2% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Azerbaijan or Peru?
- Azerbaijan, at 80.0% against 79.0% in Peru as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Azerbaijan and Peru?
- 1.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Peru?
- 24 years are reported by both, from 2000 to 2024.
- How do Azerbaijan and Peru rank globally for access to anti-retroviral drugs, male?
- Azerbaijan ranks 47th and Peru ranks 49th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.